Significant Generics Opportunity

Source: IMS and analyst reports

Branded pharmaceuticals going off patent

Will drive significant generic growth for McKesson

• 24% share of

independent segment (#1)

• 20,000 pharmacy outlets

• Generic Rx GP% can be 3-5x

that of branded Rx

Previous slide

Next slide

Back to first slide

View graphic version